Aortic stenosis is the most common valvular disease in adults, with a prevalence that increases significantly with age. Amyloidosis, though rarer, is increasingly recognized as a cause of heart failure with preserved ejection fraction (HFpEF), but often remains underdiagnosed due to the lack of a standardized diagnostic pathway.
The association between aortic stenosis and cardiac amyloidosis is more frequent than previously thought. This overlap complicates diagnosis.
The congress will focus on the latest developments in diagnostic tools, imaging techniques, and emerging therapeutic strategies for the proper identification and management of patients presenting with both conditions.